Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Phreesia

Phreesia Shows Rising Price Performance With Jump To 84 RS Rating

A Relative Strength Rating upgrade for Phreesia shows improving technical performance.

Investors Business Daily

Stocks Generating Improved Relative Strength: Phreesia

A Relative Strength Rating upgrade for Phreesia shows improving technical performance. Will it continue?

Investors Business Daily

Phreesia Sees RS Rating Improve To 73

Phreesia shows improving price performance, earning an upgrade to its IBD Relative Strength Rating

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Stocks Showing Rising Market Leadership: Phreesia Earns 83 RS Rating

Phreesia shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 80 to 83.

Investors Business Daily

Phreesia Earns Technical Rating Upgrade

Phreesia shows improving price performance, earning an upgrade to its IBD Relative Strength Rating

Investors Business Daily

Stocks Generating Improved Relative Strength: Phreesia

Phreesia shows improving price performance, earning an upgrade to its IBD Relative Strength Rating

Investors Business Daily

Phreesia Clears Key Benchmark, Hitting 80-Plus RS Rating

Phreesia shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 82.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Stocks Flashing Renewed Technical Strength: Phreesia

A Relative Strength Rating upgrade for Phreesia shows improving technical performance.

Investors Business Daily

Stocks Showing Improved Relative Strength: Phreesia

Phreesia shows improving price performance, earning an upgrade to its IBD Relative Strength Rating

Investors Business Daily

Stocks To Watch: Phreesia Sees RS Rating Jump To 92

Phreesia shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.

Investors Business Daily

Phreesia Earns Relative Strength Rating Upgrade; Hits Key Benchmark

Phreesia shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 77 to 87.

Investors Business Daily

Phreesia Joins Elite Club Of Stocks With RS Ratings Over 90

Phreesia shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.

Investors Business Daily

Stocks Showing Market Leadership: Phreesia Earns 92 RS Rating

Phreesia shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.

Investors Business Daily

Phreesia Shows Rising Price Performance With Jump To 91 RS Rating

Phreesia shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Phreesia Shows Improved Relative Price Performance; Still Shy Of Benchmark

A Relative Strength Rating upgrade for Phreesia shows improving technical performance. Will it continue?

TechRadar

Almost a million ConnectOnCall users may have had data stolen by hackers

900,000 patients who called doctors out of hours may have had their information stolen following data breach.

Investors Business Daily

Phreesia Getting Closer To Key Technical Benchmark

A Relative Strength Rating upgrade for Phreesia shows improving technical performance. Will it continue?

Tom’s Guide

Over 900,000 Americans just had their personal and health info exposed in medical data breach — names, phone numbers, treatments and SSNs

Preesia subsidiary ConnectOnCall has revealed that it fell victim to a breach in which an unauthorized attacker managed to access app data and provider-patient communications.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

A Look Ahead: Phreesia's Earnings Forecast

Phreesia (NYSE:PHR) will release its quarterly earnings report on Monday, 2024-12-09. Here's a brief overview for investors ahead of the announcement.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 16, 2022

Benzinga

Piper Sandler Maintains Overweight Rating for Phreesia: Here's What You Need To Know

Piper Sandler has decided to maintain its Overweight rating of Phreesia (NYSE:PHR) and lower its price target from $42.00 to $32.00. Shares of Phreesia are trading down 1.07% over the last 24 hours, at $17.50 per share. A move to $32.00 would account for a 82.86% increase from the current…

Benzinga

Analyst Ratings for Phreesia

Phreesia (NYSE:PHR) has observed the following analyst ratings within the last quarter:

Benzinga

Earnings Preview: Phreesia

Phreesia (NYSE:PHR) is set to give its latest quarterly earnings report on Thursday, 2022-06-02. Here's what investors need to know before the announcement. Analysts estimate that Phreesia will report an earnings per share (EPS) of $-0.95.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2022

Upgrades

Benzinga

Expert Ratings For Phreesia

Phreesia (NYSE:PHR) has observed the following analyst ratings within the last quarter:

1 2

Organisations

Investor Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Social Security

3,207 stories

Read news from The Economist, FT, and more,
with one subscription

Places

United States

303,150 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.